Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Levels of C-reactive protein are associated with response to infliximab therapy in patients with Crohn's disease.
Jürgens M, Mahachie John JM, Cleynen I, Schnitzler F, Fidder H, van Moerkercke W, Ballet V, Noman M, Hoffman I, van Assche G, Rutgeerts PJ, van Steen K, Vermeire S. Jürgens M, et al. Among authors: van steen k, van moerkercke w, van assche g. Clin Gastroenterol Hepatol. 2011 May;9(5):421-7.e1. doi: 10.1016/j.cgh.2011.02.008. Epub 2011 Feb 17. Clin Gastroenterol Hepatol. 2011. PMID: 21334460
Targeting TNF-α for the treatment of inflammatory bowel disease.
Billiet T, Rutgeerts P, Ferrante M, Van Assche G, Vermeire S. Billiet T, et al. Among authors: van assche g. Expert Opin Biol Ther. 2014 Jan;14(1):75-101. doi: 10.1517/14712598.2014.858695. Epub 2013 Nov 11. Expert Opin Biol Ther. 2014. PMID: 24206084 Review.
Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease.
Drobne D, Bossuyt P, Breynaert C, Cattaert T, Vande Casteele N, Compernolle G, Jürgens M, Ferrante M, Ballet V, Wollants WJ, Cleynen I, Van Steen K, Gils A, Rutgeerts P, Vermeire S, Van Assche G. Drobne D, et al. Among authors: van steen k, van assche g. Clin Gastroenterol Hepatol. 2015 Mar;13(3):514-521.e4. doi: 10.1016/j.cgh.2014.07.027. Epub 2014 Jul 25. Clin Gastroenterol Hepatol. 2015. PMID: 25066841
A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitis.
Arias MT, Vande Casteele N, Vermeire S, de Buck van Overstraeten A, Billiet T, Baert F, Wolthuis A, Van Assche G, Noman M, Hoffman I, D'Hoore A, Gils A, Rutgeerts P, Ferrante M. Arias MT, et al. Among authors: van assche g. Clin Gastroenterol Hepatol. 2015 Mar;13(3):531-8. doi: 10.1016/j.cgh.2014.07.055. Epub 2014 Aug 10. Clin Gastroenterol Hepatol. 2015. PMID: 25117777
The use of prognostic factors in inflammatory bowel diseases.
Billiet T, Ferrante M, Van Assche G. Billiet T, et al. Among authors: van assche g. Curr Gastroenterol Rep. 2014 Nov;16(11):416. doi: 10.1007/s11894-014-0416-y. Curr Gastroenterol Rep. 2014. PMID: 25262067 Review.
399 results